The PERK-eIF2alpha phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells
Authors: Kusio-Kobiałka M., Podszywalow-Bartnicka P., Peidis P., Glodkowska-Mrowka E., Wolanin K., Leszak G., Seferynska I., Stoklosa T., Koromilas A., Piwocka K.
Published in: Cell Cycle
Publication type: article
Subject areas: Biochemistry, Genetics and Molecular Biology; Medicine
SJR best quartile: Q1